Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Cardiovascular Clinical Trials Market size was over USD 5.91 billion in 2024 and is poised to exceed USD 12.45 billion by 2037, growing at over 5.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cardiovascular clinical trials is evaluated at USD 6.19 billion.
The growth of the market is prompted by the rising incidence of cardiac disorders like cardiac arrest, stoke, and coronary artery diseases. According to the World Heart Federation, cardiovascular diseases are ranked among the top diseases causing deaths and the global estimated deaths from cardiovascular diseases in the year 2021 were approximately 205 million. Besides, the enhancement in related government and industrial funding, along with the rising need to achieve greater cost avoidance in Phase III trials, are also driving market growth.
